Fredun Pharmaceuticals Limited
FREDUN
Rank in Stocks
#15201
Fredun Pharmaceuticals Ltd. specializes in the development, manufacturing, and... Fredun Pharmaceuticals Ltd. specializes in the development, manufacturing, and commercialization of a diverse range of products, including pharmaceuticals, nutraceuticals, and various herbal and dietary supplements for human consumption, alongside its animal healthcare portfolio. Nariman Bamansha Medhora established the company on June 8, 1987, and its main operations are conducted from Mumbai, India.
Share Price
$16.31
Last synced: 2026-11-12
Market Cap
$275.62M
Change (1 day)
2.51%
Change (1 year)
155.18%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Fredun Pharmaceuticals Limited (FREDUN)
Category
Healthcare
EPS for Fredun Pharmaceuticals Limited (FREDUN)
EPS as of June 2026 TTM: $0.30
According to Fredun Pharmaceuticals Limited's latest financial reports, its current EPS (TTM) is $0.30. At the end of 2025 the company had an EPS of $0.17, an increase over its 2024 EPS of $0.13.
EPS history for Fredun Pharmaceuticals Limited from 2011 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $0.30 | 76.53% |
| 2025 | $0.17 | 23.18% |
| 2024 | $0.13 | 37.49% |
| 2023 | $0.10 | 46.12% |
| 2022 | $0.07 | 191.30% |
| 2021 | $0.02 | 9.00% |
| 2020 | $0.02 | -62.05% |
| 2019 | $0.06 | 78.78% |
| 2018 | $0.03 | -5.18% |
| 2017 | $0.03 | 43.23% |
| 2016 | $0.02 | 294.83% |
| 2015 | $0.01 | 1.75% |
| 2014 | $0.01 | 2,750.00% |
| 2013 | 0.00 | -102.99% |
| 2012 | $-0.01 | -1,057.14% |
| 2011 | 0.00 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $1.69 | 463.15% |
US
|
|
| $1.93 | 543.39% |
SE
|
|
| $6.91 | 2,203.90% |
FR
|
|
| $0.02 | -93.50% |
HK
|
|
| $2.71 | 802.97% |
IT
|
Questions about Fredun Pharmaceuticals Limited's earnings per share (EPS)
What is Fredun Pharmaceuticals Limited's earnings per share (EPS)?
Fredun Pharmaceuticals Limited's earnings per share (EPS) over the last twelve months is $0.30, as of Jun 2026.
What was Fredun Pharmaceuticals Limited's earnings per share (EPS) in 2025?
In 2025, Fredun Pharmaceuticals Limited's earnings per share (EPS) was $0.17, 30.77% more than in 2024 ($0.13).
How has Fredun Pharmaceuticals Limited's earnings per share (EPS) changed since 2020?
From 2020 to 2025, Fredun Pharmaceuticals Limited's earnings per share (EPS) went from $0.02 to $0.17, an average growth of 53.42% a year.
How does Fredun Pharmaceuticals Limited's earnings per share (EPS) compare with similar companies?
Fredun Pharmaceuticals Limited's earnings per share (EPS) ($0.30) is higher than that of 1 of the 5 similar companies listed above. The highest among them is Ipsen S.A., with $6.91.